Related Experiment Video
Updated: Dec 7, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Mumps Vaccines: Current Challenges and Future Prospects
1Department of Epidemic Diseases Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Abstract:
Five decades have passed since the first mumps vaccine was licensed. Over this period, a resurgence of mumps infections has been recorded worldwide. Although global mumps infections have been controlled through vaccination, outbreaks are still on the rise, including in populations with high vaccination coverage. Several epidemiological studies suggest that this infectious virus continues to be a worldwide public health threat. The development and deployment of an improved, prophylactic mumps vaccine that provides long-lasting protection is indeed a priority. The purpose of this review is to provide an immuno-biological perspective on mumps vaccines. Here, we review the virology of mumps, licensed mumps vaccines, and the typical immune responses elicited following mumps vaccination. Furthermore, we discuss the limitations and challenges of the currently licensed mumps vaccines and provide strategies for the development of an improved mumps vaccine.
Insights
Despite widespread vaccination, mumps outbreaks persist globally. This review examines current mumps vaccines, their limitations, and strategies for developing improved vaccines offering long-lasting protection against mumps virus.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Mumps infections have resurged globally despite decades of vaccination.
- Outbreaks occur even in highly vaccinated populations, posing a public health threat.
Purpose of the Study:
- To provide an immuno-biological perspective on mumps vaccines.
- To review mumps virology, current vaccines, and immune responses.
- To discuss limitations and propose strategies for improved mumps vaccine development.
Main Methods:
- Literature review of mumps virology.
- Analysis of licensed mumps vaccines and their immunogenicity.
- Examination of epidemiological data on mumps outbreaks.
- Discussion of challenges and future directions for vaccine development.
Main Results:
- Current mumps vaccines face limitations in providing long-lasting protection.
- Resurgence of mumps highlights the need for enhanced vaccine efficacy.
- Understanding immune responses is crucial for next-generation vaccine design.
Conclusions:
- An improved mumps vaccine offering durable protection is a priority.
- Addressing current vaccine limitations is essential for controlling mumps outbreaks.
- Future strategies should focus on developing vaccines with superior and sustained immunogenicity.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

